TRIM22 Antikörper
-
- Target Alle TRIM22 Antikörper anzeigen
- TRIM22 (Tripartite Motif Containing 22 (TRIM22))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TRIM22 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Spezifität
- Reacts with human 57 kDa Staf-50
- Kreuzreaktivität (Details)
- May cross react with proteins from other species due to sequence homology
- Aufreinigung
- Purified (protein A)
- Immunogen
- Synthetic peptide derived from an internal domain of human TRIM22
- Top Product
- Discover our top product TRIM22 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/50 to 1/500 - WB : 1/200 to 1/2 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- TRIM22 (Tripartite Motif Containing 22 (TRIM22))
- Andere Bezeichnung
- E3 Ubiquitin-Protein Ligase TRIM22 (TRIM22 Produkte)
- Hintergrund
- Interferon-induced antiviral protein involved in cell innate immunity. The antiviral activity could in part be mediated by TRIM22-dependent ubiquitination of viral proteins. Plays a role in restricting the replication of HIV-1, encephalomyocarditis virus (EMCV) and hepatitis B virus (HBV). Acts as a transcriptional repressor of HBV core promoter.
- UniProt
- Q8IYM9
-